Products

RetCAD
Thirona
Ophthalmology AI
RetCAD is a CE-certified AI software product from Thirona that analyzes color fundus images for the presence of Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR), aiding in early detection and grading of these vision-threatening conditions.
LungQ Software
Thirona
Oncology AI
LungQ by Thirona is an AI-powered software for comprehensive analysis of thoracic CT scans, providing quantitative insights for the diagnosis, treatment planning, and follow-up of various lung diseases.
LungQ
Thirona
Radiology & Imaging AI
LungQ by Thirona offers AI-powered analysis of thoracic CT scans for specialized clinical care and interventional pulmonology, providing quantitative support for diagnosis, treatment planning, and follow-up examinations of lung diseases.

See all 3 products →

About Thirona

Thirona is a Dutch MedTech company specializing in artificial intelligence (AI) for advanced medical image analysis, primarily focusing on thoracic CT scans, chest X-rays, and retinal images. Founded by scientists Eva van Rikxoort and Bram van Ginneken from the Radboud University Medical Center, Thirona aims to bridge the gap between academic advancements in medical image analysis and practical clinical application. Their vision is to make personalized lung care widely accessible, enabling every patient to receive optimal and timely treatment regardless of disease complexity.

Thirona’s flagship product, LungQ™, provides AI-powered quantitative analysis of thoracic CT scans, assisting clinicians in detecting, measuring, and tracking pulmonary diseases with high precision. This platform supports specialized clinical care, interventional pulmonology, and aids in diagnosis and follow-up examinations for conditions such as COPD, asthma, lung cancer, and bronchiectasis. Thirona also offers CAD4TB for chest X-ray analysis, focusing on tuberculosis screening, and RetCAD for retinal image analysis, addressing conditions like diabetic retinopathy. The company’s solutions are designed to improve patient outcomes, streamline clinical workflows, and support research in precision medicine.

Focus Areas

AI-powered lung image analysis precision medicine for lung diseases drug development pulmonary interventions COPD Bronchiectasis Disease Severe Asthma Cystic Fibrosis lung cancer thoracic CT scans chest X-rays

Business Intelligence

TechnologyLungQ (modular AI technology for thoracic CT analysis, including advanced segmentation and quantification capabilities, deep learning models), CAD4TB (AI for chest X-rays)

What Physicians Need to Know

AI-Powered Lung Image Analysis
Thirona specializes in high-precision AI-powered analysis of thoracic CT scans, offering quantitative support for diagnosis, treatment planning, and follow-up examinations of lung diseases. Their LungQ® platform utilizes advanced AI for lung segmentation and quantification, interpreting CT data with anatomical precision, even in complex or severely diseased lungs.
Precision Medicine for Lung Diseases
The company's technology enables precision-driven treatment by providing objective and quantitative insights into lung anatomy and pathology. This supports personalized procedural planning, real-time guidance, and longitudinal follow-up for various lung conditions.
Drug Development Support
Thirona's AI-powered quantitative chest CT analysis is crucial in respiratory clinical trials for drug and treatment development. It provides non-invasive, precise, and objective assessment of anatomical abnormalities and disease severity, helping to identify treatment targets, assess patient eligibility, and monitor treatment response.
Pulmonary Interventions
Thirona's LungQ® platform supports the entire interventional pathway, from pre-procedural planning and intra-operative navigation to post-treatment assessment. They partner with MedTech companies developing interventional devices, navigation technologies, and robotic bronchoscopy systems.
Disease Specialization
Thirona's solutions are extensively validated across major lung diseases and therapeutic areas, including COPD, Bronchiectasis Disease, Severe Asthma, Cystic Fibrosis, and lung cancer.
Thoracic CT Scans & Chest X-rays
Their primary focus is on AI-powered analysis of thoracic CT scans, providing detailed segmentation and quantification of lung structures. While their core expertise is CT, they also contribute to projects involving chest X-rays for early diagnosis.
Key Differentiators
Thirona offers market-unique segmentation and quantification capabilities, an accelerated path from technology to clinically ready solutions, and a proven track record in interventional pulmonology implementations. Their algorithms are trained on deeply characterized phenotypic datasets for robustness across disease severity, scan quality, and anatomical complexity.
Technology Stack
The core of Thirona's technology is the LungQ® platform, which consists of a wide range of AI-based algorithms. These algorithms are trained on disease-specific datasets and enable high-resolution segmentation of anatomy and pathological features across lobar, segmental, and subsegmental levels, quantitative analysis of parenchymal, bronchial, and pulmonary vascular abnormalities, and image registration.
Physician Tip

For physicians, Thirona's LungQ® platform offers objective and precise quantitative analysis of lung CT scans, moving beyond subjective interpretation. This can lead to more accurate diagnoses, personalized treatment planning (e.g., for bronchial rheoplasty or endobronchial valve placement in emphysema), and sensitive monitoring of disease progression and treatment response. The AI-powered tools can assist in identifying specific disease subtypes, planning optimal biopsy routes for lung cancer, and providing intra-operative guidance for minimally invasive interventions, potentially saving physician time and improving diagnostic yield.

Thirona's LungQ® modules are designed for integration into early R&D, interventional systems, and clinical workflows. They offer OEM-ready imaging solutions for integration into clinical decision-support environments. Thirona partners with MedTech companies and their solutions are available through AI marketplaces and distribution platforms, such as Blackford Analysis, and they have a strategic partnership with Pulmonx for their StratX® platform.

Products by Thirona

3 products in the directory

RetCAD
Thirona
Ophthalmology AI
RetCAD is a CE-certified AI software product from Thirona that analyzes color fundus images for the presence of Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR), aiding in early detection and grading of these vision-threatening conditions.
LungQ Software
Thirona
Oncology AI
LungQ by Thirona is an AI-powered software for comprehensive analysis of thoracic CT scans, providing quantitative insights for the diagnosis, treatment planning, and follow-up of various lung diseases.
LungQ
Thirona
Radiology & Imaging AI
LungQ by Thirona offers AI-powered analysis of thoracic CT scans for specialized clinical care and interventional pulmonology, providing quantitative support for diagnosis, treatment planning, and follow-up examinations of lung diseases.

Videos

News, demos, and interviews about Thirona.

Loading videos...

Videos load interactively. If none appear, search YouTube for Thirona →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Thirona's AI-powered LungQ® platform provides quantitative analysis of thoracic CT scans for a multitude of lung and respiratory diseases. This includes common conditions like COPD, Severe Asthma, and lung cancer, as well as rarer conditions such as Bronchiectasis Disease and Cystic Fibrosis.
Thirona prioritizes quality, compliance, and data protection, adhering to the highest international standards. Their product development follows a certified Quality Management System (ISO 13485) and internationally recognized frameworks for medical device software and data governance regulations, including EU MDR 2017/745 and U.S. FDA Quality System Regulation (21 CFR Part 820).
Thirona's flagship product is LungQ®, an AI-powered platform for analyzing thoracic CT scans, which aids in diagnosis, treatment planning, and follow-up examinations for various lung diseases. They also developed CAD4TB for chest X-ray analysis and RetCAD for retinal scans, and during the COVID-19 pandemic, they introduced CAD4COVID for both X-ray and CT.
Yes, Thirona's LungQ® technology is designed for integration into clinical decision-support environments and supports the entire interventional pathway, from pre-procedural planning to post-treatment assessment. Their solutions also play a vital role in advancing clinical trials for pharmaceutical drug development by providing objective, quantitative assessments of treatment efficacy and disease mechanisms.
Thirona collaborates with research institutions, academic hospitals, pharmaceutical innovators, and MedTech companies to advance precision medicine and develop novel therapies. Notable partnerships include those with Pulmonx for emphysema treatment, VIDA Diagnostics for respiratory clinical trials, and the COPD Foundation for large-scale research studies on COPD.
Thirona's AI-powered LungQ® engine performs automated analytics of clinical data from lung CT scans, enabling precise identification and quantification of anatomical structures and disease-related abnormalities. This allows for more effective, personalized patient treatment by providing objective insights into disease progression, treatment response, and patient phenotyping.
While specific pricing details are not publicly available, Thirona's focus is on providing reliable and user-friendly solutions that bridge the gap between academic ideas and clinical use, with a commitment to consistent quality and customer success. For inquiries regarding product information or support, they can be contacted directly via email or through their website.

Related Companies

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Siemens Healthineers is a leading global medical technology company that pioneers breakthroughs in healthcare. The company focuses on medical technology and diagnostics, offering a wide range of products including imaging systems, laboratory diagnostics, and advanced therapies. Their innovations aim to improve patient outcomes and make healthcare more accessible and sustainable. Siemens Healthineers has a strong […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.